European Journal of Surgical Oncology
Volume 35, Issue 2 , Pages 168-173 , February 2009

Prediction of rectal lymph node metastasis by pelvic computed tomography measurement

  • F. Pomerri

      Affiliations

    • Department of Diagnostic Sciences and Special Therapies, Radiology Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), University of Padua, Via Giustiniani 2, 35128 Padua, Italy
    • ,
  • I. Maretto

      Affiliations

    • Department of Oncological and Surgical Sciences, Clinica Chirurgica II, University Hospital of Padua, Via Giustiniani, 2, 35128 Padua, Italy
    • ,
  • S. Pucciarelli

      Affiliations

    • Department of Oncological and Surgical Sciences, Clinica Chirurgica II, University Hospital of Padua, Via Giustiniani, 2, 35128 Padua, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 049 821 2075; fax: +39 049 651891.
    • ,
  • M. Rugge

      Affiliations

    • Department of Diagnostic Sciences and Special Therapies, Pathology Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), University of Padua, Via Gabelli 61, 35128 Padua, Italy
    • ,
  • S. Burzi

      Affiliations

    • Department of Diagnostic Sciences and Special Therapies, Radiology Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), University of Padua, Via Giustiniani 2, 35128 Padua, Italy
    • ,
  • M. Zandonà

      Affiliations

    • Department of Diagnostic Sciences and Special Therapies, Radiology Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), University of Padua, Via Giustiniani 2, 35128 Padua, Italy
    • ,
  • A. Ambrosi

      Affiliations

    • Department of Oncological and Surgical Sciences, Clinica Chirurgica II, University Hospital of Padua, Via Giustiniani, 2, 35128 Padua, Italy
    • ,
  • E. Urso

      Affiliations

    • Department of Oncological and Surgical Sciences, Clinica Chirurgica II, University Hospital of Padua, Via Giustiniani, 2, 35128 Padua, Italy
    • ,
  • P.C. Muzzio

      Affiliations

    • Department of Diagnostic Sciences and Special Therapies, Radiology Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), University of Padua, Via Giustiniani 2, 35128 Padua, Italy
    • ,
  • D. Nitti

      Affiliations

    • Department of Oncological and Surgical Sciences, Clinica Chirurgica II, University Hospital of Padua, Via Giustiniani, 2, 35128 Padua, Italy

,Accepted 14 February 2008.

References 

  1. Greene FL, Page DL, Fleming ID, et al. AJCC American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed.. New York: Springer; 2002;
  2. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–646
  3. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–1740
  4. Bipat S, Glas AS, Slors FJM, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Radiology. 2004;232:773–783
  5. Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology. 2004;232:335–346
  6. Goh V, Halligan S, Bartram CI. Local radiological staging of rectal cancer. Clin Radiol. 2004;59:215–226
  7. Skandarajah AR, Tjandra JJ. Preoperative loco-regional imaging in rectal cancer. Aust NZ J Surg. 2006;76:497–504
  8. Kotanagy H, Fukuoka T, Shibata Y, et al. The size of regional lymph nodes does not correlate with the presence or absence of metastases in lymph nodes in rectal cancer. J Surg Oncol. 1993;54:252–254
  9. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003;227:371–377
  10. Kim JH, Beets GL, Kim MJ, et al. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size?. Eur J Radiol. 2004;52:78–83
  11. Minsky BD, Cohen AM, Kemeny N, et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol. 1992;10:1218–1224
  12. Pucciarelli S, Friso ML, Toppan P, et al. Preoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer: preliminary results. Ann Surg Oncol. 2000;7:38–44
  13. Theodoropoulos G, Wise WE, Padmanabhan A, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum. 2002;45:895–903
  14. Chan AKP, Wong AO, Langevin J, et al. “Sandwich” preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival. Int J Radiat Oncol Biol Phys. 1997;37:629–637
  15. Mohiuddin M, Regine WF, John WJ, et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys. 2000;46:883–888
  16. Gerard JP, Chapet O, Nemoz C, et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomized trial. J Clin Oncol. 2004;22:2404–2409
  17. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93:1215–1223
  18. Das P, Skibber JM, Rodriguez-Bigas MA, et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007;109:1750–1755
  19. Bedrosian I, Rodriguez-Bigas MA, Feig B, et al. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg. 2004;8:56–62
  20. Stipa F, Zernecke A, Moore HG, et al. Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?. Ann Surg Oncol. 2004;11:187–191
  21. Read TE, Andujar JE, Caushaj PF, et al. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum. 2004;47:825–831
  22. Pucciarelli S, Capirci C, Emanuele U, et al. Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol. 2005;12:111–116
  23. Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240:711–717
  24. Kim CJ, Yeatman TJ, Coppola D, et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg. 2001;234:352–358
  25. Schell SR, Zlotecki RA, Mendenhall WM, et al. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg. 2002;194:584–590
  26. Bonnen M, Crane C, Vauthey JN, et al. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys. 2004;60:1098–1105
  27. Blomqvist L, Holm T, Nyren S, et al. MR imaging and computed tomography in patients with rectal tumours clinically judged as locally advanced. Clin Radiol. 2002;57:211–218
  28. Kim NK, Kim MJ, Yun SH, et al. Comparative study of transrectal ultrasonography, pelvic computerized tomography, and magnetic resonance imaging in preoperative staging of rectal cancer. Dis Colon Rectum. 1999;42:770–775
  29. Chiesura-Corona M, Muzzio PC, Giust G, et al. Rectal cancer: CT local staging with histopathologic correlation. Abdom Imaging. 2001;26:134–138
  30. Harewood GC, Wiersma MJ, Nelson H, et al. A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. Gastroenterology. 2002;123:24–32
  31. Pucciarelli S, Toppan P, Friso ML, et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum. 2004;47:1798–1807
  32. Enker EW, Thaler TH, Cranon LM, et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995;181:335–346
  33. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341:457–460
  34. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2(8514):996–999
  35. Herbst F. Pelvic radiological imaging: a surgeon's perspective. Eur J Radiol. 2003;47:135–141
  36. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90:355–364
  37. Kim CK, Kim SH, Chun HK, et al. Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging. Eur Radiol. 2006;16:972–980
  38. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114–1123
  39. Ratto C, Ricci R, Rossi C, et al. Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer. Dis Colon Rectum. 2002;45:733–742
  40. Kahn H, Alexander A, Rakinic J, et al. Preoperative staging of irradiated rectal cancers using digital rectal examination, computed tomography, endorectal ultrasound, and magnetic resonance imaging does not accurately predict T0,N0 pathology. Dis Colon Rectum. 1997;40:140–144
  41. Rau B, Hunerbein M, Barth C, et al. Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer. Surg Endosc. 1999;13:980–984
  42. Denecke T, Rau B, Hoffmann KT, et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?. Eur Radiol. 2005;15:1658–1666
  43. Maretto I, Pomerri F, Pucciarelli S, et al. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol. 2007;14:455–461

PII: S0748-7983(08)00076-0

doi: 10.1016/j.ejso.2008.02.006

European Journal of Surgical Oncology
Volume 35, Issue 2 , Pages 168-173 , February 2009

Article Tools